A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

NCT02667938 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: HCP1303 capsule 5/0.2mg
DRUG: HCP1303 capsule 5/0.4mg
DRUG: HGP1201
DRUG: HCP1303 capsule 5/0.2mg placebo
DRUG: HCP1303 capsule 5/0.4mg placebo
DRUG: HGP1201 placebo

Sponsor

Hanmi Pharmaceutical Company Limited